The glitazones: proceed with caution

被引：35

作者：

Krische, D ^{[1
]}

机构：

[1] Univ Washington, Seattle, WA 98195 USA

来源：

WESTERN JOURNAL OF MEDICINE | 2000年 / 173卷 / 01期

关键词：

D O I：

10.1136/ewjm.173.1.54

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：54 / 57

页数：4

共 56 条

[1]

Akanuma Y., 1996, Diabetologia, V39, pA232

[2]

Al-Salman J, 2000, ANN INTERN MED, V132, P121, DOI 10.7326/0003-4819-132-2-200001180-00006

[3] Impaired glucose tolerance is normalized by treatment with the thiazolidinedione troglitazone [J].

Antonucci, T ;

Whitcomb, R ;

McLain, R ;

Lockwood, D .

DIABETES CARE, 1997, 20 (02) :188-193

[4]

BEEBE KL, 1999, 59 ANN M AM DIAB ASS

[5]

Charbonnel B, 1999, DIABETES, V48, pA114

[6] Pharmacologic therapy for type 2 diabetes mellitus [J].

DeFronzo, RA .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (04) :281-303

[7]

EGAN J, 1999, 59 ANN M AM DIAB ASS

[8]

Fonseca V, 1999, DIABETES, V48, pA100

[9] Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled study [J].

Fonseca, VA ;

Valiquett, TR ;

Huang, SM ;

Ghazzi, MN ;

Whitcomb, RW .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09) :3169-3176

[10] Hepatic failure in a patient taking rosiglitazone [J].

Forman, LM ;

Simmons, DA ;

Diamond, RH .

ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) :118-121

← 1 2 3 4 5 6 →